Surfactant therapy for acute respiratory distress in infants
Acute respiratory distress syndrome (ARDS) remains the primary indication for admission to paediatric intensive care units and accounts for significant mortality, morbidity and resource utilization. Respiratory infections, in particular pneumonia and severe bronchiolitis, are the most common causes...
Main Authors: | Corrado Moretti, Caterina S. Barbàra, Rosanna Grossi, Stefano Luciani, Fabio Midulla, Paola Papoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Hygeia Press di Corridori Marinella
2014-10-01
|
Series: | Journal of Pediatric and Neonatal Individualized Medicine |
Subjects: | |
Online Access: | https://www.jpnim.com/index.php/jpnim/article/view/177 |
Similar Items
-
Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
by: Morteza Habibi, et al.
Published: (2024-01-01) -
Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
by: Mandy Brasher, et al.
Published: (2021-06-01) -
DO LARGE PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME BENEFIT FROM EARLY SURFACTANT?
by: N Khosravi, et al.
Published: (2008-11-01) -
DO LARGE PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME BENEFIT FROM EARLY SURFACTANT?
by: N Khosravi, et al.
Published: (2008-10-01) -
Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
by: Ji Won Koh, et al.
Published: (2018-10-01)